Prognostic Value of Platelet to Lymphocyte Ratio in Patients with Non-Small Cell Lung Cancer

Journal Title: The Egyptian Journal of Hospital Medicine - Year 2018, Vol 72, Issue 9

Abstract

<strong>Background: </strong>The prognostic value of Platelet-to-lymphocyte ratio (PLR) in patients with non-small-cell lung cancer (NSCLC) is still indistinct. We conducted this study to assess the prognostic significance of pretreatment PLR in patients with unresectable NSCLC.<br /> <strong>Aim of the Work: </strong>to assess the prognostic significance of pre-treatment PLR in patients with NSCLC.<br /> <strong>Material and Methods: </strong>we retrospectively reviewed 130 patients treated for NSCLC with definitive/palliative chemotherapy and/or radiotherapy in Ain-Shams University hospital, Clinical Oncology department between January 2014 and December 2016. Pre-treatment CBC was available for the 130 patients to calculate PLR by dividing the absolute platelet count by the absolute lymphocytic count.<br /> <strong>Results: </strong>Out of 130 patients with available pre-treatment complete blood picture, population age ranged from 23 to 87 years. Male to female ratio was 4.8:1. Adenocarcinoma presents 51% of cases. Unresectable stage II and stage III present 2% and 27% respectively, while Stage IV presents 69%. Using a cut-off value of 150, high PLR>150 was significantly associated with poor overall survival (OS) (median OS: 10.33 months; 95% CI: 6.23-14.42), compared to patients with PLR<150; (median OS: 24.63 months, 95% CI: 11.5-37.76, p=0.008), but not PFS. In multivariate analysis, PLR>150 was an independent poor prognostic factor for OS; (HR=1.9, 95% CI; 1.092-3.3, p=0.023).    <br /> <strong>Conclusion: </strong>High PLR is associated with poor OS in patients with unresectable NSCLC.

Authors and Affiliations

Eman Helal

Keywords

Related Articles

Interferon Lambda 4 Gene (IFNL4) Linked to Hepatitis C virus clearance, treatment

Background: AdesignatedIFNL4 gene, encoding the interferon-λ4 protein (IFNL4), which is moderately similar to IFNL3, is more strongly associated with HCV clearance in individuals of African ancestry, whereas it provides...

The Prevalence and Risk Factors of Persistent Pain after Mastectomy in Saudi Females

<strong>Background: </strong>Chronic pain is known to develop after several surgeries including mastectomy. Mastectomy is the surgical treatment for breast cancer. The prevalence of chronic pain after breast surgery vari...

Role of Endovenous Laser Ablation versus Radiofrequency Ablation for Primary Varicose Veins

<strong>Background:</strong> varicose veins, a common problem with effects on quality of life, account for a significant cost burden on the health care system<strong>.</strong> They are enlarged, tortuous, subcutaneous v...

Case Report: Pituitary Macroadenoma with Calcification

<strong>Background:</strong> sellar-suprasellar tumor calcification mostly is craniopharyngioma but rarely can be found in Pituitary Adenomas. <strong>Aim of the work:</strong> This article aims to describe a case report...

Endovascular versus Open Surgical Reconstruction in Long Segment Superficial Femoral Artery Occlusive Disease

<span>Background: </span><span>The concept of endovascular intervention has been well supported by the continuous advance in technology in long segment (superficial femoral artery) SFA occlusions. The rapid evolution of...

Download PDF file
  • EP ID EP584325
  • DOI 10.12816/ejhm.2018.11166
  • Views 124
  • Downloads 0

How To Cite

Eman Helal (2018). Prognostic Value of Platelet to Lymphocyte Ratio in Patients with Non-Small Cell Lung Cancer. The Egyptian Journal of Hospital Medicine, 72(9), 5298-5303. https://europub.co.uk./articles/-A-584325